|
1
|
Pisetsky DS and Ward MM: Advances in the
treatment of inflammatory arthritis. Best Pract Res Clin Rheumatol.
26:251–261. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim Y, Oh HC, Park JW, Kim IS, Kim JY, Kim
KC, Chae DS, Jo WL and Song JH: Diagnosis and treatment of
inflammatory joint disease. Hip Pelvis. 29:211–222. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Firestein GS and McInnes IB:
Immunopathogenesis of rheumatoid arthritis. Immunity. 46:183–196.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tak PP and Breedveld FC: Current
perspectives on synovitis. Arthritis Res. 1:11–16. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoshitomi H: Regulation of immune
responses and chronic inflammation by fibroblast-like synoviocytes.
Front Immunol. 10:1395. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zuo W, Yan F, Zhang B, Li J and Mei D:
Advances in the studies of Ginkgo biloba leaves extract on
aging-related diseases. Aging Dis. 8:812–826. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nash KM and Shah ZA: Current perspectives
on the beneficial role of Ginkgo biloba in neurological and
cerebrovascular Disorders. Integr Med Insights. 10:1–9. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Le Bars PL and Kastelan J: Efficacy and
safety of a Ginkgo biloba extract. Public Health Nutr. 3((4a)):
495–499. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao G, Lyu M, Wang Y, He S, Liu X, Ni J,
Li L, Fan G, Han J, Gao X, et al: Ginkgo flavonol glycosides or
Ginkgolides tend to differentially protect myocardial or cerebral
ischemia-reperfusion injury via regulation of TWEAK-Fn14 signaling
in heart and brain. Front Pharmacol. 10:735. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jaracz S, Malik S and Nakanishi K:
Isolation of ginkgolides A, B, C, J and bilobalide from G. biloba
extracts. Phytochemistry. 65:2897–2902. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Wu Y, Yao X, Hao F, Yu C, Bao Y, Wu
Y, Song Z, Sun Y, Zheng L, et al: Ginkgolide A Ameliorates
LPS-induced inflammatory responses in vitro and in vivo. Int J Mol
Sci. 18:7942017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Liu K, Liu S, Aerqin Q and Wu X:
Role of Ginkgolides in the inflammatory immune response of
neurological diseases: A review of current literatures. Front Syst
Neurosci. 14:452020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu F, Shi W, Zhou G, Yao H, Xu C, Xiao W,
Wu J and Wu X: Ginkgolide B functions as a determinant constituent
of Ginkgolides in alleviating lipopolysaccharide-induced lung
injury. Biomed Pharmacother. 81:71–78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang H, Shi Q, Nan W, Wang Y, Wang S,
Yang F and Li G: Ginkgolide B and bilobalide promote the growth and
increase β-catenin expression in hair follicle dermal papilla cells
of American minks. Biofactors. 45:950–958. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vitolo O, Gong B, Cao Z, Ishii H, Jaracz
S, Nakanishi K, Arancio O, Dzyuba SV, Lefort R and Shelanski M:
Protection against beta-amyloid induced abnormal synaptic function
and cell death by Ginkgolide J. Neurobiol Aging. 30:257–265. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshino S and Ohsawa M: The role of
lipopolysaccharide injected systemically in the reactivation of
collagen-induced arthritis in mice. Br J Pharmacol. 129:1309–1314.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bertani B and Ruiz N: Function and
Biogenesis of Lipopolysaccharides. EcoSal Plus.
8:10.1128/ecosalplus.ESP.0001-2018. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang CF, Chau YP, Kung HN and Lu KS: The
lipopolysaccharide-induced pro-inflammatory response in RAW264.7
cells is attenuated by an unsaturated fatty acid-bovine serum
albumin complex and enhanced by a saturated fatty acid-bovine serum
albumin complex. Inflamm Res. 61:151–160. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yücel G, Zhao Z, El-Battrawy I, Lan H,
Lang S, Li X, Buljubasic F, Zimmermann WH, Cyganek L, Utikal J, et
al: Lipopolysaccharides induced inflammatory responses and
electrophysiological dysfunctions in human-induced pluripotent stem
cell derived cardiomyocytes. Sci Rep. 7:2935. 2017. View Article : Google Scholar
|
|
20
|
Cope PJ, Ourradi K, Li Y and Sharif M:
Models of osteoarthritis: The good, the bad and the promising.
Osteoarthritis Cartilage. 27:230–239. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alsaleh G, Suffert G, Semaan N, Juncker T,
Frenzel L, Gottenberg JE, Sibilia J, Pfeffer S and Wachsmann D:
Bruton's tyrosine kinase is involved in miR-346-related regulation
of IL-18 release by lipopolysaccharide-activated rheumatoid
fibroblast-like synoviocytes. J Immunol. 182:5088–5097. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin XN, Yan EZ, Wang HM, Sui HJ, Liu Z,
Gao W and Jin Y: Hyperoside exerts anti-inflammatory and
anti-arthritic effects in LPS-stimulated human fibroblast-like
synoviocytes in vitro and in mice with collagen-induced arthritis.
Acta Pharmacol Sin. 37:674–686. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grabowski PS, Wright PK, Van't Hof RJ,
Helfrich MH, Ohshima H and Ralston SH: Immunolocalization of
inducible nitric oxide synthase in synovium and cartilage in
rheumatoid arthritis and osteoarthritis. Br J Rheumatol.
36:651–655. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kawashima M, Ogura N, Akutsu M, Ito K and
Kondoh T: The anti-inflammatory effect of cyclooxygenase inhibitors
in fibroblast-like synoviocytes from the human temporomandibular
joint results from the suppression of PGE2 production. J Oral
Pathol Med. 42:499–506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu Q, Gao Y, Zhao H, Wang Z and Wang J:
Galangin protects human rheumatoid arthritis fibroblast like
synoviocytes via suppression of the NF κB/NLRP3 pathway. Mol Med
Rep. 18:3619–3624. 2018.PubMed/NCBI
|
|
26
|
Herlaar E and Brown Z: p38 MAPK signalling
cascades in inflammatory disease. Mol Med Today. 5:439–447. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schieven GL: The p38alpha kinase plays a
central role in inflammation. Curr Top Med Chem. 9:1038–1048. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yong HY, Koh MS and Moon A: The p38 MAPK
inhibitors for the treatment of inflammatory diseases and cancer.
Expert Opin Investig Drugs. 18:1893–1905. 2009. View Article : Google Scholar : PubMed/NCBI
|
